Anesthesia for Cannabis and Cannabis Products Users

Main Article Content

Suttasinee Petsakul
Suwimon Tangwiwat
Somchai Amornyotin
Nantthasorn Zinboonyahgoon
Sasikaan Nimmaanrat
Wareerat Kaikosol
Thanachporn Boonsombat
Patt Pannangpetch
Rattaphol Seangrung
Thanarat Suansanae
Sahaphume Srisuma
Ngamjit Pattaravit
Ruenreong Leelanukrom


Cannabis (marijuana) and cannabis products, derived from plants of genus Cannabis. With the legalization of cannabis and cannabis products in Thailand, their widespread use for both medical and recreational purposes have increase. However, the chemical compounds present in cannabis can have adverse effects on various systems of the body, including the nervous system, cardiovascular system, respiratory system, and immunity. These effects can lead to complications in patients using cannabis during perioperative care. The history taking in cannabis users is very important. Laboratory screening for cannabis is still inconclusive. This review aims to provide an overview of the pharmacokinetics, pharmacodynamics, potential complications, and cannabis toxicity to guide anesthetic personnel in planning and managing anesthesia in the cannabis and cannabis products users.

Article Details

Review articles


Zinboonyahgoon N, Srisuma S, Limsawart W, Rice ASC, Suthisisang C. Medicinal cannabis in Thailand: 1-year experience after legalization. Pain. 2021;162(Suppl 1):S105-9.

ฐปนวงศ์ มิตรสูงเนิน, กุลชา โทณานนท์, แพรว โคตรุฉิน, สุดา วรรณประสาท. การศึกษาความชุกและลักษณะทางคลินิกของผูู้้ป่วยจากการใช้้กัญชาเปรียบเทียบระหว่างก่อนและหลังการประกาศให้้มีการใช้้กัญชาทางการแพทย์อย่างถููกกฎหมาย พ.ศ. 2562 ในโรงพยาบาลมหาวิทยาลัย. วารสารเวชศาสตร์ฉุกเฉินแห่่งประเทศไทย. 2020;2:17-36.

Moore RA, Fisher E, Finn DP, et al. Cannabinoids, cannabis, and cannabis-based medicines for pain management: an overview of systematic reviews. Pain. 2021;162(Suppl1):S67-79.

Mohiuddin M, Blyth FM, Degenhardt L, et al. General risks of harm with cannabinoids, cannabis, and cannabis-based medicine possibly relevant to patients receiving these for pain management: an overview of systematic reviews. Pain. 2021;162(Suppl1):S80-96.

Sideli L, Trotta G, Spinazzola E, La Cascia L, Di Forti M. Adverse effects of heavy cannabis use: even plants can harm the brain. Pain. 2021;162(Suppl1):S97-104.

Shah S, Schwenk ES, Sondekoppam RV, et al. ASRA Pain medicine consensus guidelines on the management of the perioperative patient on cannabis and cannabinoids. Reg Anesth Pain Med. 2023;48:97-117.

Amornyotin S. Cannabis and endocannabinoid system. J Addict Med Ther Sci. 2021;7:004-6.

Alexander JC, Joshi GP. A review of the anesthetic implications of marijuana use. Proc (Bayl Univ Med Cent).2019;32:364-71.

Freeman TP, Hindocha C, Green SF, Bloomfield MAP. Medicinal use of cannabis-based products and cannabinoids. BMJ. 2019; 365:1141.

Cannabinoid agonists for nausea and vomiting. Gastroenterol Nurs. 2016;39:137-9.

van der Pol P, Liebregts N, Brunt T, et al. Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study. Addiction. 2014;109:1101-9.

Huestis MA. Human cannabinoid pharmacokinetics. Chem Biodivers. 2007;4:1770-804.

Lucas CJ, Galettis P, Schneider J. The pharmacokinetics and the pharmacodynamics of cannabinoids. Br J Clin Pharmacol. 2018;84:2477-82.

Ashton CH. Pharmacology and effects of cannabis: a brief review. Br J Psychiatry. 2001;178:101-6.

กระทรวงสาธารณสุข. ผลิตภัณฑ์กัญชาทางการแพทย์ [Internet]. นนทบุรี:กระทรวงสาธารณสุข [date unknown; cited 2023 Mar 7]. Available from:

Loflin M, Earleywine M. A new method of cannabis ingestion: the dangers of dabs? Addict Behav. 2014;39:1430-3.

Bidwell LC, YorkWilliams SL, Mueller RL, Bryan AD, Hutchison KE. Exploring cannabis concentrates on the legal market: User profiles, product strength, and health-related outcomes. Addict Behav Rep. 2018;8:102-6.

Morean ME, Kong G, Camenga DR, Cavallo DA, Krishnan-Sarin S. High school students’ use of electronic cigarettes to vaporize cannabis. Pediatrics. 2015;136:611-6.

Hartman RL, Brown TL, Milavetz G, et al. Controlled cannabis vaporizer administration: blood and plasma cannabinoids with and without alcohol. Clin Chem. 2015;61:850-69.

MacCoun RJ, Mello MM. Half-baked-the retail promotion of marijuana edibles. N Engl J Med. 2015;372:989-91.

Borgelt LM, Franson KL, Nussbaum AM, Wang GS. The pharmacologic and clinical effects of medical cannabis. Pharmacotherapy. 2013;33:195-209.

สุุภาพรรณ น้้อยพิทัักษ์์, ภัทราภรณ์ สมบุุศย์, พาพิรุณ น้้อยตาแสง, นภัสร์ชนันท์ เหล่่าทวีสุข, พงศ์ธารา วิจิตเวชไพศาล. กัญชา: ข้้อมููลที่จำเป็นในการระงับความรู้สึก. วิสัญญีสาร. 2022;48:75-82.

Lutge EE, Gray A, Siegfried N. The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS. Cochrane Database Syst Rev. 2013;4:CD005175.

Cooper ZD, Haney M. Comparison of subjective, pharmacokinetic, and physiological effects of marijuana smoked as joints and blunts. Drug Alcohol Depend. 2009;103:107-13.

McGilveray IJ. Pharmacokinetics of cannabinoids. Pain Res Manag. 2005;10(SupplA):15A-22A.

Irvine D, Meyer T, Williams J, Huang J. Perioperative considerations of cannabis use on anesthesia administration. APSF Newsletter. 2022;37:67-9.

Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42:327-60.

Amin MR, Ali DW. Pharmacology of medical cannabis. Adv Exp Med Biol. 2019;1162:151-65.

Adams IB, Martin BR. Cannabis: pharmacology and toxicology in animals and humans. Addiction. 1996;91:1585-614.

Devine ML, Dow GJ, Greenberg BR, et al. Adverse reactions to delta-9-tetrahydrocannabinol given as an antiemetic in a multicenter study. Clin Pharm. 1987;6:319-22.

Dow GJ, Meyers FH, Stanton W, Devine ML. Serious reactions to oral delta-9-tetrahydrocannabinol in cancer chemotherapy patients. Clin Pharm. 1984;3:14.

Claudet I, Mouvier S, Labadie M, et al. Unintentional cannabis intoxication in toddlers. Pediatrics. 2017;140:e20170017.

Ladha KS, Mistry N, Wijeysundera DN, et al. Recent cannabis use and myocardial infarction in young adults: a cross-sectional study. CMAJ. 2021;193:E1377-84.

Heizer JW, Borgelt LM, Bashqoy F, Wang GS, Reiter PD. Marijuana misadventures in children: exploration of a dose-response relationship and summary of clinical effects and outcomes. Pediatr Emerg Care. 2018;34:457-62.

Smith-Kielland A, Skuterud B. Urinary excretion of 11-nor-9-carboxy-delta9- tetrahydrocannabinol and cannabinoids in frequent and infrequent drug users. J Anal Toxicol. 1999;23:323-32.

Saitman A, Park HD, Fitzgerald RL. False-positive interferences of common urine drug screen immunoassays: a review. J Anal Toxicol. 2014;38:387-96.

Teitel A, Bozimowski G. A review of the pharmacology and anesthetic implications of cannabis. AANA J. 2020;88:237-44.

Laudanski K, Wain J. Considerations for cannabinoids in perioperative care by anesthesiologists. J Clin Med. 2022;11:558.

Echeverria-Villalobos M, Todeschini AB, Stoicea N, Fiorda-Diaz J, Weaver T, Bergese SD. Perioperative care of cannabis users: a comprehensive review of pharmacological and anesthetic considerations. J Clin Anesth. 2019;57:41-9.

Amornyotin S. Cannabis: what anesthesiologists need to know? Thai J Anesthesiol. 2022;48:177-9.

Ibera C, Shalom B, Saifi F, Shruder J, Davidson E. Effects of cannabis extract premedication on anesthetic depth. Harefuah. 2018;157:162-6.